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Abstract
Background: In laboratory mice and rats, congenic breeding is essential for analyzing the genes of interest on specific
genetic backgrounds and for analyzing quantitative trait loci. However, in theory it takes about 3–4 years to achieve a strain
carrying about 99% of the recipient genome at the tenth backcrossing (N10). Even with marker-assisted selection, the so-
called ‘speed congenic strategy’, it takes more than a year at N4 or N5.
Methodology/Principal Findings: Here we describe a new high-speed congenic system using round spermatids retrieved
from immature males (22–25 days of age). We applied the technique to three genetically modified strains of mice:
transgenic (TG), knockin (KI) and N-ethyl-N-nitrosourea (ENU)-induced mutants. The donor mice had mixed genetic
backgrounds of C57BL/6 (B6):DBA/2 or B6:129 strains. At each generation, males used for backcrossing were selected based
on polymorphic marker analysis and their round spermatids were injected into B6 strain oocytes. Backcrossing was repeated
until N4 or N5. For the TG and ENU-mutant strains, the N5 generation was achieved on days 188 and 190 and the proportion
of B6-homozygous loci was 100% (74 markers) and 97.7% (172/176 markers), respectively. For the KI strain, N4 was achieved
on day 151, all the 86 markers being B6-homozygous as early as on day 106 at N3. The carrier males at the final generation
were all fertile and propagated the modified genes. Thus, three congenic strains were established through rapid generation
turnover between 41 and 44 days.
Conclusions/Significance: This new high-speed breeding strategy enables us to produce congenic strains within about half
a year. It should provide the fastest protocol for precise definition of the phenotypic effects of genes of interest on desired
genetic backgrounds.
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Introduction
For nearly 30 years, the genetic manipulation of laboratory
mice has contributed substantially to the development of many
fields in medical research and mammalian biology. Remarkably,
by genetically altering the mouse genome with single nucleotide
precision, it is now possible to create mice with desired genetic
modifications to assess gene function in healthy animals and in
animal models for human diseases. One major issue associated
with mouse genetic engineering is that the biological function of
engineered genes can vary with their genetic background [1–3].
This often raises serious concerns, because transgenic (TG) or
knockout (or knockin, KI) mice are generated in strains that have
historically been selected for the ease and convenience of
generating the TG or knockout strain, rather than phenotypic
characterization of the mutation itself. For example, most
embryonic stem (ES) cell lines used for knockout experiments
are derived from the 129 strain. Unfortunately, however, this
strain has significant biological limitations that interfere with the
phenotypic analysis of a target mutation. It consists of a diverse
and complex family of substrains [4] and many of these have an
atypical brain structure [5]. Therefore, for facilitating definition of
transgene or gene-targeted effects over a given genetic back-
ground, the engineered gene should be introduced from the donor
strain into the desired recipient strain.
The classical protocol for such purpose is congenic breeding:
serially backcrossing the gene donor to the recipient strain
accompanied by selection for progeny carrying the desired gene
in each backcross generation. This protocol calls for 10 backcross
generations (N10), followed by an intercross (F1) to produce
founders that are homozygous for the desired gene (theoretically
more than 99% of the genome) [6]. Although the strategy is
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4943simple, the process is expensive and time consuming, requiring
roughly 3–4 years to produce any given congenic strain. To
overcome this weakness, reduction of backcross generations for the
establishment of congenic strains has been achieved using marker-
assisted selection protocols (MASP), the so-called ‘speed con-
genics’. The time required for deriving such congenic strains is
about 1–2 years, depending on the robustness and intensiveness of
the polymorphic analysis between the gene donor and recipient
strains [7].
One interesting suggestion is that the breeding cycle could be
shortened by superovulating and breeding juvenile females (3–4
weeks) followed by embryo transfer to mature females for
production of the next generation [8]. This might shorten the
generation time down to 6–7 weeks and reduce the whole
congenic procedure to 1 year. This ‘supersonic congenics’ strategy
was promising, but has not proved practical because of the limited
number of oocytes that can be produced and because there are
great individual differences in response to superovulation resumes.
We have attempted to develop another high-speed congenic
strategy through the male germline. Recently, we have shown that
the genomes of male germ cells from the first wave of
spermatogenesis have the ability to support embryonic develop-
ment to term. Mouse round spermatids—the youngest haploid
male germ cells—appear first at 17 days after birth and can be
used for the production of offspring by round spermatid injection
(ROSI) into oocytes [9]. We applied this technique to the
generation of congenic strains from mice with mixed genotypes
bearing a transgene, a targeted KI gene or chemically induced
mutant genes. At each generation, males used for backcrossing
were selected based on polymorphic marker analysis: low density
screening MASP using 74–176 markers distributed uniformly
throughout the genome. The recipient strain for the expected
genetic background was C57BL/6 for all lines of congenics. The
results were very consistent and the time for producing a congenic
strain was reduced significantly. Therefore, our high-speed
congenic system would be very useful for the accelerated analysis
of genes of interest under a defined genetic background.
Results and Discussion
Definition of the optimal male age for spermatid
collection
In mice, round spermatids can be collected from 17-day-old
males at the earliest and their genomes can support full term
embryonic development after injection into oocytes using ROSI
[9]. However, the efficiency of producing offspring using these
round spermatids was extremely low (0.9%) because of their very
low incidence in testicular cell suspensions (,2%). This might
compromise the accurate identification of round spermatids within
a limited time of oocyte micromanipulation. Therefore, we first
checked the proportion of round spermatids in testicular cell
suspensions from males aged 18, 20, 22 and 24 days to define the
optimal age for applying ROSI. As shown in Figure 1, the
percentages of round spermatids in testicular suspension increased
consistently from days 18 to 24 with statistically significant
differences between groups (P,0.05). This resulted in easier
identification of round spermatids under a microscope: thus, the
time required for picking up a single round spermatid was roughly
60, 15, 10 and 10 sec using cell suspensions collected at days 18,
20, 22 and 24, respectively. Therefore, we defined day 22 to be the
earliest age of males that allowed the efficient identification of
round spermatids in testicular cell suspensions. Testes of the mice
at day 22 were smaller than in adults, but we could still collect
sufficient round spermatids from a single testis to perform a ROSI
experiment (about 150–250 injected oocytes).
Congenics of gene-modified strains using first-wave
round spermatids
To test whether high-speed congenics using the first wave of
round spermatids could be used practically, we applied the
technique to three different types of gene-modified strains, TG, KI
and N-ethyl-N-nitrosourea (ENU)-mutant strains. At each gener-
ation, a male used for the next application of ROSI was selected
based on showing fewer heterozygous alleles by polymorphic
markers that could identify the donor (DBA/2 and 129) and
Figure 1. Definition of the optimal male age for spermatid collection. a) Representative photomicrograph of a cell suspension prepared
from the testis of a male mouse at 24 days of age. Arrows indicate round spermatids, which are easily identified by a round nucleus and a high
cytoplasmic/nuclear ratio. b) The proportion of round spermatids among testicular cells from 18 days to 24 days after birth. The percentages of round
spermatids in testicular suspension increased consistently from days 18 to 24 (P,0.05 between groups). The cells were counted in two different
males by two different operators. The horizontal bars indicate the average.
doi:10.1371/journal.pone.0004943.g001
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until the N4 or N5 generation. After this, additional backcrossing
was continued by natural mating to reduce the undetected gaps of
contaminating donor alleles [10].
The Vasa–Venus TG strain we used was generated from embryos
produced by IVF using (B6Cr6DBA/2)F1 strain oocytes and
B6Cr strain spermatozoa, and maintained by full-sib mating. The
N1 offspring were obtained by ICSI using a donor male at F7. As
shown in Figure 2a, N5 backcross offspring were obtained on day
188 and all 74 markers were identified as B6 homozygous in one of
two carrier males.
The Ednra
EGFP/+ KI strain was derived from ES cells with a
(B6Cr6129
+Ter/SvJcl)F1 genetic background [11]. The first N1
generation was obtained by IVF using B6Cr oocytes and
spermatozoa from a chimeric mouse. All 86 markers were
homozygous for B6Cr as early as at N3 (day 106; 2 out of 14
carrier males) and N4 offspring were obtained on day 151
(Figure 2b).
The ENU-induced growth differentiation factor 5 (Gdf5) mutant
line had a mixed genetic background of B6J and DBA/2J [12]. For
this combination of inbred strains, more dense polymorphic
markers were available using single nucleotide polymorphism
(SNP) assays as well as microsatellite genotyping (176 markers; see
Materials and Methods). The N5 generation was obtained on day
190 and was 97.7% (172/176) homozygous for B6J (Figure 2c).
The following N6 and N7 generations produced by IVF were
98.8% and 99.4% homozygous for B6J, respectively.
The efficiency rates in backcross breeding by ROSI in these
gene-modified strains are shown in Table 1. All the modified genes
could be propagated successfully into the next generations by
ROSI. The male carriers finally obtained were all fertile and
propagated the modified genes to the next generation by natural
mating.
Significance of congenic breeding using first-wave male
germ cells
Congenic strains have been used extensively for the study of
mouse genetics including definition of phenotypic effects of genes
on specific genetic backgrounds and identification of genes or
genomic segments affecting the phenotypes of interest by
quantitative trait locus (QTL) analysis. However, it takes about
2–3 years to construct a congenic strain with a level of genetic
homogeneity that is reliable for research (.99% or more) [6]. To
accelerate congenic breeding, MASP has been developed by
taking advantage of precise information on mouse genetics [7].
Another approach for efficient congenics should be rapid
generation turnover by assisted reproduction techniques. The
use of immature females proposed by Behringer [8] was applied
Figure 2. Time course of generation turnover and the rate of markers homozygous for the C57BL/6 (B6) type. a) Vasa–Venus transgenic
strain. All markers (n=74) were homozygous for B6 at N5 on day 188. b) Ednra
EGFP/+ knockin strain. All markers (n=86) were homozygous for B6 at N3
on day 106 and N4 offspring were obtained on day 151. c) ENU-induced Gdf5 mutant strain. The N5 generation was obtained on day 190 and was
97.7% (172/176) homozygous for B6. There were 74, 86 and 176 polymorphic markers, which identified the alleles for the C57BL/6Cr:DBA/2Cr, C57BL/
6Cr:129 and C57BL/6J:DBA/2J strains, respectively. Each generation turnover was between 42 and 45 days: the age of the donor male plus the
gestation period (20 days) minus the one-day overlap between them.
doi:10.1371/journal.pone.0004943.g002
High-Speed Congenic Strategy
PLoS ONE | www.plosone.org 3 March 2009 | Volume 4 | Issue 3 | e4943successfully to the derivation of a conplastic strain of rats [13].
However, there have been very few similar applications published,
probably because of the limited number of oocytes produced from
any one female, which may attenuate the number of carrier
females in the subsequent generations. Our high-speed congenic
system uses immature males as founders at each generation.
Unlike females, each male can produce a large number of germ
cells and multiple litters of offspring. This not only assures the safe
propagation of the target gene on to the next generation, but also
enables efficient selection of a male for the next round of ROSI,
thus significantly shortening the time for congenics.
In this study, the advantages of our high-speed congenic strategy
were shown in the KI strain, which started with a (B6Cr6129)F1
genetic background: all 86 markers were homozygous for the B6
strain as early as 106 days (N3). Apparently, it is more
straightforward to use B6 ES cells for gene targeting if the B6
genetic background is required. Several B6 ES cells are available
for gene targeting [14,15], and the International Knockout
Consortium uses C57BL/6 ES cell lines [16]. However, B6 ES
cells usually require more intense care than other 129 or hybrid ES
cells to maintain their germline transmission ability during gene
targeting. ES cells with hybrid genetic constitutions of B6 and 129
are easy to maintain and can be used efficiently for producing
gene-targeted offspring [1,11], especially by tetraploid comple-
mentation [17]. If the gene-targeted allele is of B6 origin, it may
avoid the persistence of donor genetic segments around the
targeted allele during congenic production, which inevitably
occurs when 129 ES cells are used. Thus, the combination of
gene-targeting (B66129)F1 ES cells and the new high-speed
congenic breeding may be an alternative fast protocol to generate
a B6 gene-targeting strain.
A congenic breeding strategy has also been employed
extensively in laboratory rats because it is now possible to map
the genetic variants and mutations that underlie complex disease-
related phenotypes in this species [18,19]. ROSI is successful in
some, but not all, strains of rats [20]. As the first wave of round
spermatids appears in rat testes around 26 days after birth, we
estimate that congenic rat strains could be generated within 7 or 8
months by using these germ cells [21].
We anticipate that the congenic strategy developed in this study
might be accelerated further using male germ cells that are
younger than round spermatids. This is possible theoretically,
because the genomes of primary spermatocytes—premeiotic male
germ cells—can support the full term development of embryos
[22]. Despite many efforts to improve the technique, however, the
efficiency of producing offspring using primary spermatocytes is
very low [22,23]. Therefore, at present the use of round
spermatids on days 22–25 may be the most practical range for
efficient, rapid backcross breeding in mice. As far as we know, this
is the most rapid generational turnover by sexual reproduction in
mammals.
Technical issues associated with congenics by ROSI
As mentioned above, the high-speed congenic strategy we
developed is very promising to produce congenic strains with
desired genetic backgrounds. One of the technical issues associated
with this strategy is that ROSI needs some skill and experience.
However, ROSI is generally easier to perform than conventional
ICSI because of the high survival rate of oocytes after injection:
the diameter of injection pipettes is small and the activated oocytes
used for ROSI are more resistant to the injection stimulus than
nonactivated oocytes [24]. From our experience, training of three
Table 1. Results of congenic breeding by round spermatid injection (ROSI) in three gene-modified strains.
Strain
Generation
produced
Age (day) of
male used
for ROSI
No. of oocyes
that survived
ROSI
No. (%) of
oocytes that
developed to 2-cells
No. of
2-cells
transferred
No. (%)
implanted
No. (%)
born
No. (%) of
males born
No. (%) of
male carriers
Vasa-Venus
transgenic
N1 Adult (ICSI) 16 15 (93.8 ) 15 10 (66.7 ) 5 (33.3 ) 5 (33.3 ) 5 (33.3)*
N2 24 182 164 (90.1 ) 164 69 (42.1 ) 24 (14.6 ) 12 (7.3 ) 4 (2.4 )
N3 23 123 109 (88.6 ) 109 24 (22.0 ) 4 (3.7 ) 2 (1.8 ) 1 (0.9 )
N4 22 172 156 (90.7 ) 156 51 (32.7 ) 14 (9.0 ) 6 (3.8 ) 2 (1.3 )
N5 23 134 123 (91.8 ) 123 23 (18.7 ) 10 (8.1 ) 4 (3.3 ) 2 (1.6 )
Ednra-EGFP
knockin**
N1 Adult (IVF) 166 135 (81.3 ) 135 62 (45.9 ) 49 (36.3 ) 23 (17.0 ) 12 (8.9 )
N2 24 243 196 (80.7 ) 196 63 (32.1 ) 30 (15.3 ) 10 (5.1 ) 5 (2.6 )
N3 24 261 235 (90.0 ) 235 107 (45.5 ) 52 (22.1 ) 30 (12.8 ) 14 (6.0 )
N4 25 244 215 (88.1 ) 215 72 (33.5 ) 39 (18.1 ) 19 (8.8 ) 11 (5.1 )
ENU-induced
mutant
N1 Adult (IVF) 80 49 (61.3 ) 49 Not observed 26 (53.1 ) 14 (28.6 ) 3 (6.1 )
N2 25 201 158 (78.6 ) 158 54 (34.2 ) 25 (15.8 ) 11 (7.0 ) 4 (2.5 )
N3 23 208 194 (93.3 ) 194 68 (35.1 ) 26 (13.4 ) 12 (6.2 ) 7 (3.6 )
N4 22 173 127 (73.4 ) 127 51 (40.2 ) 13 (10.2 ) 5 (3.9 ) 2 (1.6 )
N5 24 216 177 (81.9 ) 177 91 (51.4 ) 34 (19.2 ) 10 (5.6 ) 4 (2.3 )
Total (ROSI only) 2157 1854 (86.0 ) 1854 673 (36.3 ) 271 (14.6 ) 121 (6.5 ) 56 (3.0 )
Control (C57BL/6) 22–24 467 349 (74.7 ) 329 133 (40.4 ) 49 (14.9 ) 26 (7.9 )
*The implantation sites were identified as the scars of decidualization at caesarian section.
**The donor male (N0) was homozygous for the transgene.
***All genetic markers tested were homozygous for the B6 mouse strain at N3.
doi:10.1371/journal.pone.0004943.t001
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already has the basic technique for embryo handling. For ICSI,
reliable protocol papers are available [25,26] and the same
protocols can be essentially applied to ROSI. Oocytes from B6
females tend to be more sensitive to injection than those from
other strains, but this problem might be overcome by using a high
osmotic strength medium for manipulation on the microscope
stage, if necessary. In our ROSI experiments using B6 oocytes,
about 80% survived the injection whereas about 90% survived in
other strains including B6D2F1, DBA/2 and 129 (unpublished).
As shown in Table 1, we consistently obtained sufficient carrier
males for selection except for the N3 to N5 generations in the
Vasa–Venus TG strain, which were affected by an accidental
decline in the quality of recipient females, for reasons unknown.
Based on the overall efficiency in our ROSI experiments presented
in Table 1, we estimated the number of oocytes to be injected with
the aim of obtaining expected number of carrier males (Table 2).
These numbers of oocytes can be handled by one or two operators
in a single session.
One can question if epigenetic modifications might have
occurred during conception using round spermatids, because
ROSI-derived preimplantation embryos have shown some
disturbances in gene expression [27,28] and aberrant DNA
methylation [29]. However, epigenetic errors imposed on
individuals are normally erased during germ cell development
and are never transmitted to the next generation by natural
mating, as shown in mouse somatic cell cloning experiments
[30,31]. Therefore, once mated naturally, congenic strains
produced by ROSI are expected to become epigenetically
indistinguishable from those produced by conventional congenic
protocols.
Conclusions
The generation turnover time in mice can be shortened to about
40 days by using the first wave round spermatids as male gametes.
We confirmed that this breeding strategy reduced the time
required for congenesis to about half a year. This should provide
the earliest opportunities for the analysis of genes of interest under
a defined genetic background and for QTL mapping, which are
becoming integral to biomedical research using the mouse as a
model.
Materials and Methods
The origin of donor strains
The B6 substrains used in this study were B6Cr (C57BL/
6CrSlc) and B6J (C57BL/6JJcl), which were purchased from
CLEA Japan, Inc. (Kanagawa) and Japan SLC, Inc. (Shizuoka),
respectively [32]. One mature male mouse from each strain was
used as the donor of the modified gene. The TG strain we used
was Tg(Mvh-Venus)1Rbrc, which was generated by DNA nuclear
injection into zygotes derived from IVF using (B6Cr6DBA/2)F1
oocytes and B6Cr spermatozoa. The Mvh-Venus gene clearly shows
the germline origin of living cells by green fluorescence because of
the highly specific expression of the Mvh (mouse vasa homologue)
gene [33]. The strain was maintained by full-sib mating. An F7
male homozygous for the transgene was used as the donor.
The KI line we used was the Ednra
EGFP/+ strain carrying the
reporter gene for enhanced green fluorescence protein (EGFP)
that had been knocked into the Ednra (endothelin receptor type A)
locus by recombinase-mediated cassette exchange based on the
Cre-lox system [11]. The gene-targeted ES cells had the
(B6Cr6129
+Ter/SvJcl)F1 genotype. Chimeric embryos were pro-
duced by injection of ES cells into ICR blastocysts and they were
transferred into pseudopregnant ICR females. A chimeric male
thus obtained were used for producing N1 by conventional IVF
using B6Cr oocytes.
The ENU-induced mutant strain we used carried a point
mutation at the Gdf5 locus. This mutation causes an amino acid
substitution in a highly conserved region of the active signaling
domain of the GDF5 (growth differentiation factor 5) protein,
leading to impaired joint formation and osteoarthritis [12]. The
donor male had a mixed genetic background of B6J and DBA/2
because the strain was generated from a cross of an ENU-
mutagenized B6J male and a wild-type DBA/2 female.
Offspring that carried modified genes were genotyped at each
generation by polymerase chain reaction (PCR) amplification with
specific primers for the given TG strain [34], by specific green
fluorescence over the body for the KI strain and by PCR-based
sequencing for the ENU mutant strain [12].
Collection of oocytes
Female B6Cr or B6J strain mice (7–10 weeks old) were each
injected with 7.5 units of equine chorionic gonadotropin followed
by injection of 7.5 units of human chorionic gonadotropin (hCG)
48 h later. Mature oocytes were collected from the oviducts 15–
17 h after hCG injection and were freed from cumulus cells by
treatment with 0.1% hyaluronidase in CZB medium [35]. The
oocytes were transferred to fresh CZB medium and incubated at
37uC in an atmosphere of 5% CO2 in air for up to 90 min before
ROSI.
Preparation of testicular cell suspensions
Spermatogenic cells were prepared mechanically as described
for hamsters [36]. Briefly, testes were removed from 18- to 25-day-
old males and placed in erythrocyte-lysing buffer (155 mM
NH4Cl/10 mM KHCO3/2 mM EDTA, pH 7.2). For the first
series of experiments to identify the optimal age of males for
donors, we used ICR males; as far as we examined there were no
strain-dependent differences in the timing of the first wave of
spermatogenesis. The tunica albuginea was removed and the
seminiferous tubule masses were transferred into cold (4uC)
Dulbecco’s phosphate buffered saline (PBS) supplemented with
5.6 mM glucose, 5.4 mM sodium lactate and 0.1 mg/ml of
polyvinyl alcohol (polyvinylpyrrolidone, PVP, in the original
report) (GL-PBS) [36]. The seminiferous tubules were cut into
small pieces and pipetted gently to disperse spermatogenic cells
into the GL-PBS. Then, the cell suspension was filtered through a
38-mm nylon mesh and washed three times by centrifugation
(200 g for 4 min). To define the optimal male age for spermatid
collection, we first examined the proportion of round spermatids in
Table 2. The numbers of superovulated females and oocytes
required for obtaining selectable numbers of carrier males, as
estimated from the data in Table 1.
Females superovulated (25–30 oocytes per
female) 4 to 5 6 to 7 7 to 8
Oocytes injected 125 167 208
Oocytes survived (80% per oocytes injected) 100 133 167
2-cells transferred (80% per oocytes survived) 80 107 133
Birth (15% per 2-cells transferred) 12 16 20
Males (50% per birth) 6 8 10
Carrier males (50% per males) 3 4 5
doi:10.1371/journal.pone.0004943.t002
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days. The percentages of round spermatids were analyzed using
arcsine transformation, followed by one-way ANOVA analysis
and a post-hoc procedure using Scheffe’s test for multiple
comparisons.
ROSI
ROSI was performed using a Piezo-driven micromanipulator
(Prime Tech Ltd., Ibaraki, Japan) as described [37,38]. The cover
of a plastic dish (Falcon no. 1006; Becton Dickinson, Franklin
Lakes, NJ) was used as a microinjection chamber. Several small
drops (,4 ml) of Hepes-buffered CZB with or without 10% PVP
were placed on the bottom and covered with mineral oil.
Spermatogenic cells were placed in one of the PVP droplets.
Before injection of the nuclei of round spermatids, oocytes were
activated by treatment with Ca
2+-free CZB medium containing
2.5 mM SrCl2 for 20 min at 37uC. Oocytes reaching telophase II
at 40–90 min after onset of activation treatment were each
injected with a round spermatid. They were kept in Hepes-CZB at
room temperature (24uC) for ,10 min before culture in CZB at
37uC under 5% CO2 in air.
Embryo culture and transfer
Embryos that reached the 2-cell stage by 24 h of culture in CZB
were transferred into the oviducts of pseudopregnant ICR strain
females (8–12 weeks old) on the day after mating (day 0.5). On day
19.5, recipient females were killed and their uteri were examined
for live term fetuses. These were nursed by lactating ICR foster
females. The day of birth was designated day 0.5 for newborns.
Care and use of animals
All procedures described here were reviewed and approved by
the Animal Experimental Committee at the RIKEN Institute.
Genotyping for MASP
Tail clips about 0.3 cm long were collected for DNA extraction,
using the Wizard Genomic DNA Purification Kit (Promega,
Madison, WI) and the DNeasy 96 Blood & Tissue Kit (#69582;
QIAGEN GmbH, Hilden, Germany) according to the manufac-
turers’ instructions. Microsatellite genotyping was carried out by
PCR for simple sequence length polymorphisms (SSLP) using
microsatellite markers. The microsatellite markers were selected
out of sequence length polymorphisms between B6 and DBA/2
and B6 and 129 strains (Mekada et al., unpublished data) (Tables
S1 and S2). PCR execution was performed using the QIAGEN
Multiplex PCR kit (#206143; QIAGEN GmbH) and the length
polymorphism was detected by agarose gel electrophoresis. Map
locations and primer sequences of the microsatellite loci were used
according to the Mouse Genome Informatics (MGI) of the Jackson
Laboratory, USA, and Mouse Microsatellite Data Base of Japan
(MMDBJ).
SNP genotyping was carried out using a TaqMan Minor
Groove Binding (MGB) assay (Applied Biosystems, Foster City,
CA). TaqMan MGB probe sets were designed based on SNP
polymorphism between C57BL/6J and DBA/2J (Table S3). PCR
execution was performed using TaqMan Genotyping Master Mix
(#4371353; Applied Biosystems). SNP polymorphisms were
detected using an ABI PRISM 7900HT Sequence Detection
System (Applied Biosystems).
Supporting Information
Table S1 Variation alleles between C57BL/6 and DBA/2
mouse strains.
Found at: doi:10.1371/journal.pone.0004943.s001 (0.02 MB
XLS)
Table S2 Variation alleles between C57BL/6 and 129 mouse
strains.
Found at: doi:10.1371/journal.pone.0004943.s002 (0.02 MB
XLS)
Table S3 The SNPs information that designed the TaqMan
MGB probe sets.
Found at: doi:10.1371/journal.pone.0004943.s003 (0.02 MB
XLS)
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